Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Sharck Soup -- Ignore unavailable to you. Want to Upgrade?

To: GREENLAW4-7 who wrote (33809)	8/31/2001 8:43:18 AM
From: Jane4IceCream	Read Replies (1) \| Respond to of 37746

IMNX is a real bio/pharma company with real earnings on the back of a blockbuster drug that has been LAGGING badly the sector. They just recieved two more "strong buy" upgrades, moved up their earning expectations for their Enbrel drug and are due to present at an important conference 14 Sept. They also have close to 1Billion in cash and are sitting very close to their 52wk low. Plus, they are constructing a large building near the Seattle waterfront to be able to handle the increase in orders. Looks ready to finally pop. Jane